Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (2024)

Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (1) https://doi.org/10.21203/rs.3.rs-2838129/v1

Видання: 2023

Видавець: Research Square Platform LLC

Автори:

  1. Scott N. Peterson
  2. Alexey M. Eroshkin
  3. Piotr Z. Kozbial
  4. Ermanno Florio
  5. Farnaz Fouladi
  6. Noah Strom
  7. Yacgley Valdes
  8. Gregory Kuehn
  9. Giorgio Casaburi
  10. Thomas Kuehn

Анотація

Abstract Background: Despite the effectiveness of colonoscopy for reducing colorectal cancer (CRC) mortality, poor screening compliance ranks CRC as the second most deadly malignancy. There is a need to develop a preventative, non-invasive diagnostic test, such as a fecal microbiota test, for early detection of both pre-cancerous adenomas and carcinomas to effectively reduce mortality. Results: We conducted a clinical meta-analysis of published deep metagenomic stool sequence datasets including 1,670 subjects from 9 countries, including 703 healthy controls, 161 precancerous colorectal adenoma (CRA), 48 advanced precancerous colorectal adenoma (CRAA) and 758 CRC cases diagnosed by colonoscopy. We analyzed these data through a novel automated machine learning workflow using a two-stage feature importance ranking and ensemble modeling method to identify and select highly predictive taxonomic and functional biomarkers. Machine learning modeling of selected features differentiated the metagenomic profiles of healthy patients from CRA, CRAA and CRC cases with an average area under the curve (AUC) for external holdout testing of 0.84 (sensitivity=0.82; specificity=0.71, accuracy=0.77) for CRC; an AUC of 0.97 (sensitivity=0.78; specificity=0.98, accuracy=0.97) for CRAA; and an AUC of 0.90 (sensitivity=0.74, specificity=0.89, accuracy=0.86) for CRA. These performance outcomes represented a 2%, 3% and 8% increase in AUC, compared to baseline ML performance, respectively. The predictive features identified for each disease class were largely distinct and represented differing proportions of taxonomic and functional features. Conclusions: The predictive taxonomic features identified for each disease class were largely distinct, whereas many functional gene features were shared across disease classes but displayed differing direction of change. Application of our ensemble approach for feature selection increased the predictive power of each disease class and moreover may generate discriminatory models with greater generalizability.

Список літератури

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (2) https://doi.org/10.3322/caac.21492
  2. Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K. The IARC Perspective on Colorectal Cancer Screening. N Engl J Med. 2018;378:1734–40.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (3) https://doi.org/10.1056/NEJMsr1714643
  3. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of Fecal Immunochemical Tests for Colorectal Cancer: Systematic Review and Meta-analysis. Ann Intern Med. 2014;160:171–81.
  4. Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med. 2009;150:162–9.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (4) https://doi.org/10.7326/0003-4819-150-3-200902030-00005
  5. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget Stool DNA Testing for Colorectal-Cancer Screening. N Engl J Med. 2014;370:1287–97.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (5) https://doi.org/10.1056/NEJMoa1311194
  6. Frank C, Sundquist J, Yu H, Hemminki A, Hemminki K. Concordant and discordant familial cancer: Familial risks, proportions and population impact: Concordant and discordant familial cancer. Int J Cancer. 2017;140:1510–6.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (6) https://doi.org/10.1002/ijc.30583
  7. Francescangeli F, De Angelis ML, Zeuner A. Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer. Nutrients. 2019;11:2936.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (7) https://doi.org/10.3390/nu11122936
  8. Johnson CM, Wei C, Ensor JE, Smolenski DJ, Amos CI, Levin B, et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24:1207–22.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (8) https://doi.org/10.1007/s10552-013-0201-5
  9. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence. Int J Cancer. 2009;125:171–80.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (9) https://doi.org/10.1002/ijc.24343
  10. Garcia S, Pruitt SL, Singal AG, Murphy CC. Colorectal cancer incidence among Hispanics and non-Hispanic Whites in the United States. Cancer Causes Control. 2018;29:1039–46.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (10) https://doi.org/10.1007/s10552-018-1077-1
  11. Greathouse KL, White JR, Padgett RN, Perrotta BG, Jenkins GD, Chia N, et al. Gut microbiome meta-analysis reveals dysbiosis is independent of body mass index in predicting risk of obesity-associated CRC. BMJ Open Gastroenterol. 2019;6:e000247.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (11) https://doi.org/10.1136/bmjgast-2018-000247
  12. Lee SH, Yun Y, Kim SJ, Lee E-J, Chang Y, Ryu S, et al. Association between Cigarette Smoking Status and Composition of Gut Microbiota: Population-Based Cross-Sectional Study. J Clin Med. 2018;7:E282.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (12) https://doi.org/10.3390/jcm7090282
  13. Rodriguez-Gonzalez A, Orio L. Microbiota and Alcohol Use Disorder: Are Psychobiotics a Novel Therapeutic Strategy? Curr Pharm Des. 2020;26:2426–37.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (13) https://doi.org/10.2174/1381612826666200122153541
  14. Allen JM, Mailing LJ, Niemiro GM, Moore R, Cook MD, White BA, et al. Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans. Med Sci Sports Exerc. 2018;50:747–57.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (14) https://doi.org/10.1249/MSS.0000000000001495
  15. Dai Z, co*ker OO, Nakatsu G, Wu WKK, Zhao L, Chen Z, et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome. 2018;6:70.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (15) https://doi.org/10.1186/s40168-018-0451-2
  16. Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019;25:667–78.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (16) https://doi.org/10.1038/s41591-019-0405-7
  17. Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25:679.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (17) https://doi.org/10.1038/s41591-019-0406-6
  18. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, et al. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota. Science. 2012;338:120–3.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (18) https://doi.org/10.1126/science.1224820
  19. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host Microbe. 2013;14:207–15.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (19) https://doi.org/10.1016/j.chom.2013.07.007
  20. Wu S, Rhee K-J, Albesiano E, Rabizadeh S, Wu X, Yen H-R, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15:1016–22.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (20) https://doi.org/10.1038/nm.2015
  21. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinforma Oxf Engl. 2010;26:139–40.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (21) https://doi.org/10.1093/bioinformatics/btp616
  22. Law CW, Chen Y, Shi W, Smyth GK. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15:R29.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (22) https://doi.org/10.1186/gb-2014-15-2-r29
  23. Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature. NIH Public Access; 2020;579:567.
  24. Mecham BH, Nelson PS, Storey JD. Supervised normalization of microarrays. Bioinforma Oxf Engl. 2010;26:1308–15.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (23) https://doi.org/10.1093/bioinformatics/btq118
  25. Wirbel J, Zych K, Essex M, Karcher N, Kartal E, Salazar G, et al. Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox. Genome Biol. 2021;22:93.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (24) https://doi.org/10.1186/s13059-021-02306-1
  26. Yu J, Feng Q, Wong SH, Zhang D, Liang Q yi, Qin Y, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. BMJ Publishing Group; 2017;66:70–8.
  27. Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat Commun. 2015;6:6528.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (25) https://doi.org/10.1038/ncomms7528
  28. Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10:766.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (26) https://doi.org/10.15252/msb.20145645
  29. Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25:968–76.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (27) https://doi.org/10.1038/s41591-019-0458-7
  30. Gao R, Zhu Y, Kong C, Xia K, Li H, Zhu Y, et al. Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer. Front Cell Infect Microbiol. 2021;11:657867.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (28) https://doi.org/10.3389/fcimb.2021.657867
  31. Gupta A, Dhakan DB, Maji A, Saxena R, P.K. VP, Mahajan S, et al. Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India. Bordenstein S, editor. mSystems. 2019;4:e00438-19, /msystems/4/6/msys.00438 – 19.atom.
  32. Vogtmann E, Hua X, Zeller G, Sunagawa S, Voigt AY, Hercog R, et al. Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing. PLOS ONE. 2016;11:e0155362.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (29) https://doi.org/10.1371/journal.pone.0155362
  33. Spanogiannopoulos P, Kyaw TS, Guthrie BGH, Bradley PH, Lee JV, Melamed J, et al. Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism. Nat Microbiol. 2022;7:1605–20.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (30) https://doi.org/10.1038/s41564-022-01226-5
  34. Hannigan GD, Duhaime MB, Ruffin MT, Koumpouras CC, Schloss PD. Diagnostic Potential and Interactive Dynamics of the Colorectal Cancer Virome. mBio. 2018;9:e02248-18.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (31) https://doi.org/10.1128/mBio.02248-18
  35. Beghini F, McIver LJ, Blanco-Míguez A, Dubois L, Asnicar F, Maharjan S, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife [Internet]. eLife Sciences Publications, Ltd; 2021 [cited 2022 Mar 31];10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096432/
  36. Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353–61.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (32) https://doi.org/10.1093/nar/gkw1092
  37. Bose S, Das C, Banerjee A, Ghosh K, Chattopadhyay M, Chattopadhyay S, et al. An ensemble machine learning model based on multiple filtering and supervised attribute clustering algorithm for classifying cancer samples. PeerJ Comput Sci. 2021;7:e671.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (33) https://doi.org/10.7717/peerj-cs.671
  38. Drewes JL, White JR, Dejea CM, Fathi P, Iyadorai T, Vadivelu J, et al. High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia. NPJ Biofilms Microbiomes. 2017;3:34.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (34) https://doi.org/10.1038/s41522-017-0040-3
  39. Pushalkar S, Ji X, Li Y, Estilo C, Yegnanarayana R, Singh B, et al. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol. 2012;12:144.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (35) https://doi.org/10.1186/1471-2180-12-144
  40. Loftus M. Bacterial community structure alterations within the colorectal cancer gut microbiome. 2021;18.
  41. Wang G, Yu Y, Wang Y-Z, Wang J-J, Guan R, Sun Y, et al. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy. J Cell Physiol. 2019;234:17023–49.
    Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (36) https://doi.org/10.1002/jcp.28436
  42. Supplementary Tables Legends.
  43. Supplementary Table S1. Top 800 features list (by disease class). A full list of taxonomy and KO features derived from FIRE and SIAMCAT analysis).
  44. Supplementary Tables S2. Taxonomic key for Fig. 8.

Дані публікації

Кількість цитувань 0
Кількість джерел у списку літератури: 44
Видання індексується в Scopus Ні
Видання індексується в Web of Science Ні
Meta-analysis of Multi-functional Biomarkers for Discovery and Predictive Modeling of Colorectal Adenoma and Carcinoma (2024)

FAQs

What are the biomarkers for Mcrc? ›

Patients who are diagnosed with stage IV (metastatic) colorectal cancer should be tested for at least four predictive biomarkers:KRAS, NRAS, BRAF, andHER2.

What are the biomarkers for early detection of colorectal cancer? ›

Germ-line APC mutations are considered an early detection marker because nearly 100% of individuals with the mutation will develop colon cancer in the future. For example, RFLP of chromosome 5q21–22 (for loss of the APC gene) has been shown to be useful for premorbid diagnosis and counseling in FAP.

What is the prognostic biomarker for colorectal cancer? ›

Of these biomarkers, CEA and CA19-9 have been the most studied because of their impact on the diagnosis and prognosis of CRC patients, but their specificity and sensitivity at early diagnosis are limited23,24.

What is the marker for colon carcinoma? ›

Tumor markers: Colorectal cancer cells sometimes make substances called tumor markers that can be found in the blood. The most common tumor marker for colorectal cancer is the carcinoembryonic antigen (CEA).

What are the biomarkers for various cancers? ›

Cancer biomarkers can be DNA, mRNA, proteins, metabolites, or processes such as apoptosis, angiogenesis or proliferation. The markers are produced either by the tumor itself or by other tissues, in response to the presence of cancer or other associated conditions, such as inflammation.

What are predictive biomarkers in colorectal cancer? ›

Other potential predictive biomarkers which are proposed in colon cancer immunotherapy include PD-L1 expression level, tumor mutation burden (TMB), tumor-infiltrating lymphocytes (TILs), gut microbiota, ctDNA, and circulating immune cells (20–24).

What are the inflammatory markers for colorectal cancer? ›

C-reactive protein (CRP) is a highly sensitive marker of inflammation that has the potential to be used to predict colorectal cancer (14, 15).

What is the blood based biomarker for colorectal cancer? ›

The risk of CRC can be estimated by detecting the degree of DNA methylation of the specific promoter region of SEPT9 in the peripheral blood. Thus methylation of target DNA sequence in the promoter region of SEPT9 v2 transcript is associated with colorectal cancer.

What is the single most important prognostic indicator of colorectal carcinoma? ›

Stage is the most important prognostic factor for colorectal cancer. The lower the stage at diagnosis, the better the outcome.

What is the marker for colon cancer prognosis? ›

Tumor Markers Found in the Blood

Carcinoembryonic antigen (CEA) level: The tumor marker most often used in colorectal cancer. This level can be checked before surgery to predict prognosis, can be used during therapy to watch response to treatment, or when you are done treatment to watch for recurrence.

What is the difference between prognostic biomarker and predictive biomarker? ›

Prognostic biomarkers are often identified from observational data and are regularly used to identify patients more likely to have a particular outcome. To identify a predictive biomarker, there generally should be a comparison of a treatment to a control in patients with and without the biomarker.

What are the biomarkers of cholangiocarcinoma? ›

Carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA), either alone or in combination with other biomarkers, are the most commonly studied biomarkers in the serum.

What are biomarkers in translational oncology? ›

From early discovery stages through clinical support, translational biomarkers are used to identify a compound's impact on organs or tissues before a clinical effect is evident. Biomarkers are divided into three general classes: target biomarkers, mechanism biomarkers and disease biomarkers.

What is the best serologic marker for colonic carcinoma? ›

Tumor Markers Found in the Blood
  • Carcinoembryonic antigen (CEA) level: The tumor marker most often used in colorectal cancer. ...
  • CA 19-9: A blood marker that may be high in colorectal cancer.
  • Chromosome 18q loss of heterozygosity (18qLOH): Often applied in patients with stage II or III colorectal cancer.
Aug 8, 2022

What are immuno oncology biomarkers? ›

Examples of biomarkers in the immunotherapy landscape include (1) soluble factors such as serum proteins, (2) tumor-specific factors such as receptor expression patterns and components of the microenvironment, and (3) host genomic factors.

Top Articles
Latest Posts
Article information

Author: Greg O'Connell

Last Updated:

Views: 5229

Rating: 4.1 / 5 (42 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Greg O'Connell

Birthday: 1992-01-10

Address: Suite 517 2436 Jefferey Pass, Shanitaside, UT 27519

Phone: +2614651609714

Job: Education Developer

Hobby: Cooking, Gambling, Pottery, Shooting, Baseball, Singing, Snowboarding

Introduction: My name is Greg O'Connell, I am a delightful, colorful, talented, kind, lively, modern, tender person who loves writing and wants to share my knowledge and understanding with you.